X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6909) 6909
Publication (917) 917
Book Review (815) 815
Conference Proceeding (46) 46
Book Chapter (25) 25
Dissertation (11) 11
Web Resource (3) 3
Magazine Article (2) 2
Newspaper Article (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
voriconazole (6131) 6131
index medicus (4988) 4988
humans (4401) 4401
male (2270) 2270
antifungal agents - therapeutic use (2184) 2184
microbiology (1870) 1870
female (1767) 1767
pharmacology & pharmacy (1567) 1567
antifungal agents - pharmacology (1538) 1538
infectious diseases (1425) 1425
middle aged (1413) 1413
triazoles - therapeutic use (1324) 1324
adult (1305) 1305
fluconazole (1243) 1243
itraconazole (1225) 1225
amphotericin-b (1159) 1159
pyrimidines - therapeutic use (1159) 1159
microbial sensitivity tests (1045) 1045
antifungal agents (986) 986
antifungal agents - administration & dosage (917) 917
aged (913) 913
mycology (899) 899
triazoles - pharmacology (894) 894
aspergillosis (859) 859
treatment outcome (803) 803
amphotericin b (753) 753
aspergillosis - drug therapy (743) 743
posaconazole (731) 731
pyrimidines - pharmacology (712) 712
caspofungin (700) 700
infections (700) 700
invasive aspergillosis (687) 687
mycoses (674) 674
mycoses - drug therapy (615) 615
pharmacokinetics (613) 613
therapy (602) 602
triazoles - administration & dosage (598) 598
animals (573) 573
health aspects (573) 573
adolescent (557) 557
infection (553) 553
susceptibility (553) 553
epidemiology (552) 552
antifungal agents - adverse effects (540) 540
transplantation (533) 533
fungal-infections (526) 526
immunology (522) 522
amphotericin b - therapeutic use (516) 516
aspergillus (506) 506
pyrimidines - administration & dosage (506) 506
drug resistance, fungal (498) 498
fungi (491) 491
immunocompromised host (483) 483
antifungal agents - pharmacokinetics (476) 476
diagnosis (464) 464
amphotericin b - pharmacology (447) 447
child (439) 439
retrospective studies (428) 428
risk factors (421) 421
candida - drug effects (419) 419
young adult (419) 419
fluconazole - pharmacology (413) 413
lipopeptides (412) 412
safety (412) 412
care and treatment (400) 400
voriconazole - therapeutic use (399) 399
mycoses - microbiology (397) 397
fungal infections (387) 387
triazoles - adverse effects (385) 385
efficacy (380) 380
drug therapy, combination (378) 378
ophthalmology (373) 373
dermatology (371) 371
itraconazole - pharmacology (371) 371
aspergillosis - microbiology (363) 363
analysis (350) 350
invasive fungal-infections (348) 348
echinocandins (342) 342
triazoles - pharmacokinetics (338) 338
in-vitro (337) 337
resistance (333) 333
pyrimidines - adverse effects (330) 330
candida (325) 325
liposomal amphotericin-b (320) 320
drug therapy (318) 318
mortality (317) 317
surgery (310) 310
research (303) 303
drug interactions (296) 296
candidiasis - drug therapy (294) 294
aged, 80 and over (288) 288
management (286) 286
aspergillus fumigatus - drug effects (283) 283
internal medicine (283) 283
veterinary sciences (279) 279
keratitis (276) 276
antifungal susceptibility (270) 270
triazoles (269) 269
oncology (267) 267
pyrimidines - pharmacokinetics (266) 266
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6265) 6265
Spanish (204) 204
French (163) 163
German (102) 102
Japanese (87) 87
Korean (41) 41
Turkish (32) 32
Chinese (23) 23
Italian (17) 17
Portuguese (15) 15
Polish (10) 10
Russian (10) 10
Czech (4) 4
Hungarian (4) 4
Dutch (2) 2
Slovenian (2) 2
Danish (1) 1
Estonian (1) 1
Hebrew (1) 1
Icelandic (1) 1
Persian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Mycoses, ISSN 0933-7407, 05/2011, Volume 54, Issue 3, pp. 230 - 233
Antifungal prophylaxis during first remission induction chemotherapy for acute myelogenous leukaemia requires broad spectrum azoles. In a clinical trial,... 
Voriconazole
Journal Article
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ISSN 1058-4838, 05/2019, Volume 68, Issue 12, pp. 1981 - 1989
Isavuconazole was compared to caspofungin followed by oral voriconazole in a Phase 3, randomized, double-blind, multinational clinical trial for the primary... 
isavuconazole | voriconazole | caspofungin | Candida
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 09/2017, Volume 83, Issue 9, pp. 1954 - 1965
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10020, pp. 760 - 769
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 07/2018, Volume 84, Issue 7, pp. 1587 - 1597
AimsThe aims of the present study were to characterize the pharmacokinetics of voriconazole in renal transplant recipients and to identify factors... 
polymorphism | voriconazole | CYP2C19 | dosing simulation | renal transplant recipients | population pharmacokinetics | CYP2C19 polymorphism | ADULT PATIENTS | PRACTICE GUIDELINES | 2016 UPDATE | INVASIVE FUNGAL-INFECTIONS | INTRAVENOUS VORICONAZOLE | DISEASES SOCIETY | DOSAGE REGIMENS | SERUM CONCENTRATIONS | PHARMACOLOGY & PHARMACY | STEM-CELL TRANSPLANTATION | TROUGH LEVELS | Antifungal Agents - adverse effects | Biological Variation, Population - physiology | Body Weight | Prospective Studies | Humans | Middle Aged | Biological Availability | Male | Transplant Recipients | Intestinal Absorption | Dose-Response Relationship, Drug | Young Adult | Voriconazole - administration & dosage | Time Factors | Invasive Fungal Infections - drug therapy | Antifungal Agents - pharmacokinetics | Adult | Female | Immunosuppressive Agents - administration & dosage | Voriconazole - adverse effects | Administration, Oral | Graft Rejection - prevention & control | Postoperative Period | Cytochrome P-450 CYP2C19 - genetics | Genotype | Voriconazole - pharmacokinetics | Models, Biological | Cytochrome P-450 CYP2C19 - metabolism | Immunosuppressive Agents - adverse effects | Polymorphism, Single Nucleotide | Graft Rejection - immunology | Antifungal Agents - administration & dosage | Invasive Fungal Infections - immunology | Kidney Transplantation - adverse effects | Kidneys | Analysis | Cytochrome P-450 | Mycoses | Organ transplant recipients | Genetic aspects | Transplantation | Index Medicus | Original
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 01/2015, Volume 162, Issue 2, pp. 81 - 89
Journal Article
Medical Mycology, ISSN 1369-3786, 2018, Volume 56, Issue 3, pp. 263 - 278
Journal Article
Journal Article
The Journal of Dermatology, ISSN 0385-2407, 09/2019, Volume 46, Issue 9, pp. e327 - e328
Journal Article
The Journal of Dermatology, ISSN 0385-2407, 08/2019, Volume 46, Issue 8, pp. e287 - e288
Journal Article
Journal Article
11/2010
Voriconazole, a triazole antifungal, is gaining popularity in the treatment of invasive fungal infections, mostly in the immuno-compromised patients.... 
voriconazole | hypoglycemia | Drug interaction | glimepiride
Web Resource
10/2013
Purpose: To determine the susceptibilities of fluconazole and voriconazole based on slime production by Candida spp. Methods: Candida strains (115) isolated in... 
Fluconazole | Candida | Voriconazole | Antifungal susceptibility | Slime
Web Resource